Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 1;27(2):184-191.
doi: 10.1097/MCO.0000000000000992. Epub 2023 Nov 6.

Urea cycle disorders in critically Ill adults

Affiliations
Review

Urea cycle disorders in critically Ill adults

Micah T Long et al. Curr Opin Clin Nutr Metab Care. .

Abstract

Purpose of review: Urea cycle disorders (UCDs) cause elevations in ammonia which, when severe, cause irreversible neurologic injury. Most patients with UCDs are diagnosed as neonates, though mild UCDs can present later - even into adulthood - during windows of high physiologic stress, like critical illness. It is crucial for clinicians to understand when to screen for UCDs and appreciate how to manage these disorders in order to prevent devastating neurologic injury or death.

Recent findings: Hyperammonemia, particularly if severe, causes time- and concentration-dependent neurologic injury. Mild UCDs presenting in adulthood are increasingly recognized, so broader screening in adults is recommended. For patients with UCDs, a comprehensive, multitiered approach to management is needed to prevent progression and irreversible injury. Earlier exogenous clearance is increasingly recognized as an important complement to other therapies.

Summary: UCDs alter the core pathway for ammonia metabolism. Screening for mild UCDs in adults with unexplained neurologic symptoms can direct care and prevent deterioration. Management of UCDs emphasizes decreasing ongoing ammonia production, avoiding catabolism, and supporting endogenous and exogenous ammonia clearance. Core neuroprotective and supportive critical care supplements this focused therapy.

PubMed Disclaimer

References

    1. Redant S, Warrillow S, Honoré PM. Ammonia and nutritional therapy in the critically ill: when to worry, when to test and how to treat? Curr Opin Clin Nutr Metab Care 2023; 26:160–166.
    1. Long MT, Coursin DB. Undifferentiated nonhepatic hyperammonemia in the ICU: diagnosis and management. J Crit Care 2022; 70:154042.
    1. Shakerdi L, Ryan A. Drug-induced hyperammonaemia. J Clin Pathol 2023; 76:501–509.
    1. Ibrahim MS, Gold JI, Woodall A, et al. Diagnostic and management issues in patients with late-onset ornithine transcarbamylase deficiency. Children (Basel) 2023; 10:1368.
    1. Wang S, Chen J, Zhu X, et al. Clinical and genetic analysis of a case of late onset carbamoyl phosphate synthase I deficiency caused by CPS1 mutation and literature review. BMC Med Genomics 2023; 16:145.